Clinical relevance of mortalin overexpression in hepatocellular carcinoma (HCC) was supported by the study in which advanced aggressive stages of HCC and early recurrence were correlated with a higher level of mortalin expression. The gene discussed is HSPA9; the disease is hepatocellular carcinoma.